Furthermore, intraperitoneal injection of TRAIL-expressing ADSCs in a mouse model of metastatic ovarian cancer resulted in preferential homing of ADSCs in the tumor and efficient TRAIL delivery with a significant decrease in tumor volume. Here, TNFSF10 is linked to neoplasm.